Form 13-F position report

ORTHOFIX MED INC

Reported by Nuveen Asset Management LLC

OFIX CUSIP 68752M108 Manager CIK 0001521019

Reported 224,077 shares, unchanged from the prior quarter.

Reported value 7.8%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q2 2023
Shares 224,077 Quarter-end amount reported
Reported value $4,046,831 Fair value at quarter end
Consecutive quarters held 17 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2020-03-31 11611000
2020-06-30 16720000
2020-09-30 10297000
2020-12-31 11017000
2021-03-31 10703000
2021-06-30 9772000
2021-09-30 8757000
2021-12-31 6407000
2022-03-31 7097000
2022-06-30 3575000
2022-09-30 2667000
2022-12-31 2882000
2023-03-31 3753000
2023-06-30 4046831
2023-09-30 2837687
2023-12-31 3549189
2024-03-31 3046543
2024-06-30 3672039
2024-09-30 1952687
2024-12-31 1547305

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for ORTHOFIX MED INC held by Nuveen Asset Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2024 Reduced 88,620 -36,392 (-29.1%) < 0.01% $1,547,305 2025-02-14
Q3 2024 Reduced 125,012 -151,914 (-54.9%) < 0.01% $1,952,687 2024-11-14
Q2 2024 Added 276,926 +67,109 (32.0%) < 0.01% $3,672,039 2024-08-09
Q1 2024 Reduced 209,817 -53,476 (-20.3%) < 0.01% $3,046,543 2024-05-13
Q4 2023 Added 263,293 +42,633 (19.3%) < 0.01% $3,549,189 2024-02-14
Q3 2023 Reduced 220,660 -3,417 (-1.5%) < 0.01% $2,837,687 2023-11-14
Q2 2023 Unchanged 224,077 0 (0.0%) < 0.01% $4,046,831 2023-08-14
Q1 2023 Added 224,077 +83,661 (59.6%) < 0.01% $3,753,000 2023-05-15
Q4 2022 Added 140,416 +873 (0.6%) < 0.01% $2,882,000 2023-02-14
Q3 2022 Reduced 139,543 -12,321 (-8.1%) < 0.01% $2,667,000 2022-11-14
Q2 2022 Reduced 151,864 -69,593 (-31.4%) < 0.01% $3,575,000 2022-08-15
Q1 2022 Reduced 221,457 -731 (-0.3%) < 0.01% $7,097,000 2022-05-16
Q4 2021 Reduced 222,188 -7,524 (-3.3%) < 0.01% $6,407,000 2022-02-14
Q3 2021 Reduced 229,712 -13,909 (-5.7%) < 0.01% $8,757,000 2021-11-12
Q2 2021 Reduced 243,621 -3,276 (-1.3%) < 0.01% $9,772,000 2021-08-16
Q1 2021 Reduced 246,897 -9,421 (-3.7%) < 0.01% $10,703,000 2021-05-17
Q4 2020 Reduced 256,318 -74,350 (-22.5%) < 0.01% $11,017,000 2021-02-16
Q3 2020 Reduced 330,668 -191,805 (-36.7%) < 0.01% $10,297,000 2020-11-16
Q2 2020 Added 522,473 +107,925 (26.0%) < 0.01% $16,720,000 2020-08-14
Q1 2020 Added 414,548 +10,119 (2.5%) < 0.01% $11,611,000 2020-05-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

172 managers reported ORTHOFIX MED INC for Q2 2023.

Managers reporting ORTHOFIX MED INC in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 5,957,719 -49,141 < 0.01% $107,596,405 20 qtrs
First Light Asset Management LLC Reduced 2,459,129 -191,842 3.48% $44,411,870 2 qtrs
ARMISTICE CAPITAL LLC Added 2,436,000 +600,000 0.64% $43,994,160 3 qtrs
VANGUARD GROUP INC Reduced 2,406,280 -23,954 < 0.01% $43,457,417 20 qtrs
Rubric Capital Management LP Added 2,392,412 +348,698 1.85% $43,206,961 2 qtrs
SEGALL BRYANT & HAMILL LLC Reduced 2,065,583 -20,143 0.39% $37,304,429 20 qtrs
STATE STREET CORPORATION Added 1,581,014 +15,098 < 0.01% $28,553,113 20 qtrs
DIMENSIONAL FUND ADVISORS LP Added 1,178,787 +28,746 < 0.01% $21,289,431 20 qtrs
Paradice Investment Management LLC Reduced 940,975 -11,792 1.27% $16,994,009 20 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 707,418 +26,255 < 0.01% $12,775,974 21 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 14, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
224,077
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.